Clinical Trial Update: Mirabegron, Propevirine, Solifenacin for Treatment of Lower Urinary Tract Symptoms During Intravesical BCG Instillation [Phase 3]

View source ↗

Summary

Phase 3 trial update on mirabegron, propevirine, and solifenacin for lower urinary tract symptoms during intravesical BCG instillation.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Voiding Disorders

Drugs mentioned

• Mirabegron (mirabegron)
• Propevirine (propevirine)
• Solifenacin (solifenacin)

Snippet

Sponsor: Mansoura University | Conditions: Voiding Disorders | Phase 3 | Status: UNKNOWN